SCHEMBL2941238

SCHEMBL2941238

CC(C)N1CCC(C(=O)Nc2c(C(=O)Nc3ccc(Cl)cn3)oc3ccccc23)CC1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 5/20 0.62
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ MEN1 O00255 5/20 0.52
▸ KMT2A Q03164 5/20 0.52
▸ MAPT P10636 5/20 0.49
▸ HSD17B10 Q99714 4/20 0.49
▸ KDM4E B2RXH2 4/20 0.49
▸ TSHR P16473 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ TP53 P04637 2/20 0.49
▸ HPGD P15428 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ POLB P06746 2/20 0.48
▸ RXFP1 Q9HBX9 2/20 0.48
▸ GAA P10253 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ DHODH Q02127 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13290428 0.89 F10 (0.61) F10SMN1; SMN2KDM4ETSHRTP53
SCHEMBL2949510 0.89 SMN1; SMN2 (0.58) F10SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL13515762 0.88 MEN1 (0.64) F10SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL13664965 0.88 SMN1; SMN2 (0.55) F10SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL2947303 0.88 SMN1; SMN2 (0.55) F10SMN1; SMN2KMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL2942003 0.87 SMN1; SMN2 (0.55) F10SMN1; SMN2KMT2AKDM4EALDH1A1
SCHEMBL2948474 0.87 SMN1; SMN2 (0.55) F10SMN1; SMN2KMT2AMAPTKDM4E
SCHEMBL13744526 0.87 F10 (0.60) F10SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL13744525 0.87 F10 (0.59) F10SMN1; SMN2MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL2943011 0.87 SMN1; SMN2 (0.54) F10SMN1; SMN2KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1489078-B1 BENZOFURAN DERIVATIVE MITSUBISHI TANABE PHARMA CORP (JP) 2010-01-06 — — EP disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 — — US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 — — US disclosed
CN-100439351-C Benzofuran derivative TANABE SEIYAKU CO (JP) 2008-12-03 — — CN disclosed
US-20050282808-A1 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2005-12-22 — — US disclosed
CN-1656086-A Benzofuran derivative TANABE SEIYAKU CO (JP) 2005-08-17 — — CN disclosed
EP-1489078-A1 BENZOFURAN DERIVATIVE Tanabe Seiyaku Co., Ltd. (JP) 2004-12-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282808-A1 Benzofuran derivative F12, F2, F11 F10 5/4885SMN1; SMN2 3151/4885MEN1 2756/4885
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 F10 5/4885SMN1; SMN2 3067/4885MEN1 2864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback